Pinnacle Wealth Management Advisory Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Pinnacle Wealth Management Advisory Group's EW Position: Q2 2026 in Review
Pinnacle Wealth Management Advisory Group increased its Edwards Lifesciences (EW) stake by 5.9% in Q2 2026, buying an estimated $18.8K and bringing the position to 4,018 shares worth $363K. The position accounts for 0.02% of the portfolio, ranked #361.
Pinnacle Wealth Management Advisory Group first reported a position in EW in Q1 2023 and has held it in 5 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Pinnacle Wealth Management Advisory Group held 4,018 shares of Edwards Lifesciences worth $363K as of Q2 2026.
- Pinnacle Wealth Management Advisory Group bought 224 Edwards Lifesciences shares in Q2 2026, an estimated $18.8K.
- Edwards Lifesciences made up 0.02% of Pinnacle Wealth Management Advisory Group's portfolio in Q2 2026, its #361 holding.
- Pinnacle Wealth Management Advisory Group first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 5 quarters since.
- 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2026, filed 5 Aug 2026.